(Q36945868)

17 August 2017

1 reference

title

Japanese guidelines for prevention of perioperative infections in urological field (English)

1 reference

17 August 2017

1 reference

Tetsuro Matsumoto

1

1 reference

17 August 2017

Hiroshi Kiyota

2

1 reference

17 August 2017

Masanori Matsukawa

3

1 reference

17 August 2017

Mitsuru Yasuda

4

1 reference

17 August 2017

Soichi Arakawa

5

1 reference

17 August 2017

Koichi Monden

6

1 reference

17 August 2017

Japanese Society of UTI Cooperative Study Group (Chairman; Tetsuro Matsumoto)

7

1 reference

17 August 2017

1 October 2007

1 reference

International Journal of Urology

17 August 2017

1 reference

17 August 2017

14

1 reference

17 August 2017

10

1 reference

17 August 2017

890-909

1 reference

Staphylococcus aureus bacteriuria and surgical site infections by methicillin-resistant Staphylococcus aureus

17 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Complications of laparoscopic procedures in urology: experience with 2,407 procedures at 4 German centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Prophylactic antibiotherapy in urological surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

A multicenter comparison of oral lomefloxacin versus parenteral cefotaxime as prophylactic agents in transurethral surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Prophylactic chemotherapy with fosfomycin trometamol during transurethral surgery and urological manoeuvres. Results of a multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Antibacterial prophylaxis in urology: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Guidelines for the perioperative prophylaxis in urological interventions of the urinary and male genital tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Treatment and prevention of infective endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Influence of a prophylactic single dose of ciprofloxacin on the level of resistance of Escherichia coli to fluoroquinolones in urology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Perioperative antibiotic prophylaxis in urology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Primary endoscopic treatment of ureteric calculi. A review of 378 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Value of porphylactic antibacterial therapy in instrumentation of urinary tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Day-case ureteroscopy: an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Perioperative antibiotic prophylaxis in ureteroscopic stone removal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Single dose antibiotic prophylaxis in high risk patients undergoing transurethral prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Antibiotic prophylaxis in patients undergoing prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Prophylactic antibiotics in transurethral prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Oral ciprofloxacin as prophylaxis in transurethral resection of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Relative Value of Antibiotics and Catheter Care in the Prevention of Urinary Tract Infection after Transurethral Prostatic Resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

The use of ceftriaxone in the prevention of urinary tract infection in patients undergoing transurethral resection of the prostate (TUR-P).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Antibiotic prophylaxis for transurethral prostatic resection in men with preoperative urine containing less than 100,000 bacteria per ml: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective study of ciprofloxacin vs piperacillin/tazobactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

The problem of infection after prostatic biopsy: the case for the transperineal approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Bacteraemia after urological instrumentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Bacteremia following transurethral instrumentation. The predictive value of a serum bactericidal activity test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Bacteraemia after manipulation of the urinary tract. The importance of pre-existing urinary tract disease and compromised host defences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Spreading sepsis by cystoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Pharmacokinetics in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Topical perioperative antibiotic prophylaxis for minor clean inguinal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Antimicrobial prophylaxis in management of urinary tract stones by extracorporeal shock-wave lithotripsy: is it necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Incidence of bacteremia and bacteriuria in patients with non-infection-related urinary stones undergoing extracorporeal shock wave lithotripsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Risk of bacteraemia during extracorporeal shock wave lithotripsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Incidence of urinary tract infection in patients without bacteriuria undergoing SWL: comparison of stone types

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Is there a role for antibiotic cycling in the intensive care unit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Antibiotic cycling tested in nosocomial infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: executive summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Infectious complications of combination anticancer chemotherapy for urogenital cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

Chemotherapy for germ cell tumours: prophylactic ciprofloxacin reduces the incidence of neutropenic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2007.01869.X

10.1111/J.1442-2042.2007.01869.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference